Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
ID_report: ID of the individual that can be publically shared, e.g. as listed in a publication
Reference: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
Remarks: remarks about the individual
Gender: gender individual
All options:
- ? = unknown
- - = not applicable
- F = female
- M = male
- rF = raised as female
- rM = raised as male
Consanguinity: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:
- no = non-consanguineous parents
- yes = consanguineous parents
- likely = consanguinity likely
- ? = unknown
- - = not applicable
Country: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:
- ? (unknown)
- - (not applicable)
- Afghanistan
- (Afghanistan)
- Albania
- (Albania)
- Algeria
- (Algeria)
- American Samoa
- (American Samoa)
- Andorra
- (Andorra)
- Angola
- (Angola)
- Anguilla
- (Anguilla)
- Antarctica
- (Antarctica)
- Antigua and Barbuda
- (Antigua and Barbuda)
- Argentina
- (Argentina)
- Armenia
- (Armenia)
- Aruba
- (Aruba)
- Australia
- (Australia)
- Austria
- (Austria)
- Azerbaijan
- (Azerbaijan)
- Bahamas
- (Bahamas)
- Bahrain
- (Bahrain)
- Bangladesh
- (Bangladesh)
- Barbados
- (Barbados)
- Belarus
- (Belarus)
- Belgium
- (Belgium)
- Belize
- (Belize)
- Benin
- (Benin)
- Bermuda
- (Bermuda)
- Bhutan
- (Bhutan)
- Bolivia
- (Bolivia)
- Bosnia and Herzegovina
- (Bosnia and Herzegovina)
- Botswana
- (Botswana)
- Bouvet Island
- (Bouvet Island)
- Brazil
- (Brazil)
- British Indian Ocean Territory
- (British Indian Ocean Territory)
- Brunei Darussalam
- (Brunei Darussalam)
- Bulgaria
- (Bulgaria)
- Burkina Faso
- (Burkina Faso)
- Burundi
- (Burundi)
- Cambodia
- (Cambodia)
- Cameroon
- (Cameroon)
- Canada
- (Canada)
- Cape Verde
- (Cape Verde)
- Cayman Islands
- (Cayman Islands)
- Central African Republic
- (Central African Republic)
- Central Europe
- Chad
- (Chad)
- Chile
- (Chile)
- China
- (China)
- Christmas Island
- (Christmas Island)
- Cocos (Keeling Islands)
- (Cocos (Keeling Islands))
- Colombia
- (Colombia)
- Comoros
- (Comoros)
- Congo
- (Congo)
- Cook Islands
- (Cook Islands)
- Costa Rica
- (Costa Rica)
- Cote D'Ivoire (Ivory Coast)
- (Cote D'Ivoire (Ivory Coast))
- Croatia (Hrvatska)
- (Croatia (Hrvatska))
- Cuba
- (Cuba)
- Cyprus
- (Cyprus)
- Czech Republic
- (Czech Republic)
- Denmark
- (Denmark)
- Djibouti
- (Djibouti)
- Dominica
- (Dominica)
- Dominican Republic
- (Dominican Republic)
- East Timor
- (East Timor)
- Ecuador
- (Ecuador)
- Egypt
- (Egypt)
- El Salvador
- (El Salvador)
- England
- (England)
- Equatorial Guinea
- (Equatorial Guinea)
- Eritrea
- (Eritrea)
- Estonia
- (Estonia)
- Ethiopia
- (Ethiopia)
- Falkland Islands (Malvinas)
- (Falkland Islands (Malvinas))
- Faroe Islands
- (Faroe Islands)
- Fiji
- (Fiji)
- Finland
- (Finland)
- France
- (France)
- Gabon
- (Gabon)
- Gambia
- (Gambia)
- Georgia
- (Georgia)
- Germany
- (Germany)
- Ghana
- (Ghana)
- Gibraltar
- (Gibraltar)
- Greece
- (Greece)
- Greenland
- (Greenland)
- Grenada
- (Grenada)
- Guadeloupe
- (Guadeloupe)
- Guam
- (Guam)
- Guatemala
- (Guatemala)
- Guiana, French
- (Guiana, French)
- Guinea
- (Guinea)
- Guinea-Bissau
- (Guinea-Bissau)
- Guyana
- (Guyana)
- Haiti
- (Haiti)
- Heard and McDonald Islands
- (Heard and McDonald Islands)
- Honduras
- (Honduras)
- Hong Kong
- (Hong Kong)
- Hungary
- (Hungary)
- Iceland
- (Iceland)
- India
- (India)
- Indonesia
- (Indonesia)
- Iran
- (Iran)
- Iraq
- (Iraq)
- Ireland
- (Ireland)
- Israel
- (Israel)
- Italy
- (Italy)
- Jamaica
- (Jamaica)
- Japan
- (Japan)
- Jordan
- (Jordan)
- Kazakhstan
- (Kazakhstan)
- Kenya
- (Kenya)
- Kiribati
- (Kiribati)
- Korea
- (Korea)
- Korea, North (People's Republic)
- (Korea, North (People's Republic))
- Korea, South (Republic)
- (Korea, South (Republic))
- Kosovo
- (Kosovo)
- Kuwait
- (Kuwait)
- Kyrgyzstan (Kyrgyz Republic)
- (Kyrgyzstan (Kyrgyz Republic))
- Laos
- (Laos)
- Latvia
- (Latvia)
- Lebanon
- (Lebanon)
- Lesotho
- (Lesotho)
- Liberia
- (Liberia)
- Libya
- (Libya)
- Liechtenstein
- (Liechtenstein)
- Lithuania
- (Lithuania)
- Luxembourg
- (Luxembourg)
- Macau
- (Macau)
- Macedonia
- (Macedonia)
- Madagascar
- (Madagascar)
- Malawi
- (Malawi)
- Malaysia
- (Malaysia)
- Maldives
- (Maldives)
- Mali
- (Mali)
- Mallorca
- (Mallorca)
- Malta
- (Malta)
- Marshall Islands
- (Marshall Islands)
- Martinique
- (Martinique)
- Mauritania
- (Mauritania)
- Mauritius
- (Mauritius)
- Mayotte
- (Mayotte)
- Mexico
- (Mexico)
- Micronesia
- (Micronesia)
- Moldova
- (Moldova)
- Monaco
- (Monaco)
- Mongolia
- (Mongolia)
- Montserrat
- (Montserrat)
- Morocco
- (Morocco)
- Mozambique
- (Mozambique)
- Myanmar
- (Myanmar)
- Namibia
- (Namibia)
- Nauru
- (Nauru)
- Nepal
- (Nepal)
- Netherlands
- (Netherlands)
- Netherlands Antilles
- (Netherlands Antilles)
- Neutral Zone (Saudia Arabia/Iraq)
- (Neutral Zone (Saudia Arabia/Iraq))
- New Caledonia
- (New Caledonia)
- New Zealand
- (New Zealand)
- Nicaragua
- (Nicaragua)
- Niger
- (Niger)
- Nigeria
- (Nigeria)
- Niue
- (Niue)
- Norfolk Island
- (Norfolk Island)
- Northern Ireland
- (Northern Ireland)
- Northern Mariana Islands
- (Northern Mariana Islands)
- Norway
- (Norway)
- Oman
- (Oman)
- Pakistan
- (Pakistan)
- Palau
- (Palau)
- Palestine
- (Palestine)
- Panama
- (Panama)
- Papua New Guinea
- (Papua New Guinea)
- Paraguay
- (Paraguay)
- Peru
- (Peru)
- Philippines
- (Philippines)
- Pitcairn
- (Pitcairn)
- Poland
- (Poland)
- Polynesia, French
- (Polynesia, French)
- Portugal
- (Portugal)
- Puerto Rico
- (Puerto Rico)
- Qatar
- (Qatar)
- Reunion
- (Reunion)
- Romania
- (Romania)
- Russia
- (Russia)
- Russian Federation
- (Russian Federation)
- Rwanda
- (Rwanda)
- S. Georgia and S. Sandwich Isls.
- (S. Georgia and S. Sandwich Isls.)
- Saint Kitts and Nevis
- (Saint Kitts and Nevis)
- Saint Lucia
- (Saint Lucia)
- Saint Vincent and The Grenadines
- (Saint Vincent and The Grenadines)
- Samoa
- (Samoa)
- San Marino
- (San Marino)
- Sao Tome and Principe
- (Sao Tome and Principe)
- Saudi Arabia
- (Saudi Arabia)
- Scotland
- (Scotland)
- Senegal
- (Senegal)
- Serbia
- (Serbia)
- Seychelles
- (Seychelles)
- Sierra Leone
- (Sierra Leone)
- Singapore
- (Singapore)
- Slovakia (Slovak Republic)
- (Slovakia (Slovak Republic))
- Slovenia
- (Slovenia)
- Solomon Islands
- (Solomon Islands)
- Somalia
- (Somalia)
- South Africa
- (South Africa)
- Southern Territories, French
- (Southern Territories, French)
- Soviet Union (former)
- (Soviet Union (former))
- Spain
- (Spain)
- Sri Lanka
- (Sri Lanka)
- St. Helena, Ascension and Tristan da
- Cunha
- (St. Helena, Ascension and Tristan da
- Cunha)
- St. Pierre and Miquelon
- (St. Pierre and Miquelon)
- Sudan
- (Sudan)
- Sudan, South
- (Sudan, South)
- Suriname
- (Suriname)
- Svalbard and Jan Mayen Islands
- (Svalbard and Jan Mayen Islands)
- Swaziland
- (Swaziland)
- Sweden
- (Sweden)
- Switzerland
- (Switzerland)
- Syria
- (Syria)
- Taiwan
- (Taiwan)
- Tajikistan
- (Tajikistan)
- Tanzania
- (Tanzania)
- Thailand
- (Thailand)
- Togo
- (Togo)
- Tokelau
- (Tokelau)
- Tonga
- (Tonga)
- Trinidad and Tobago
- (Trinidad and Tobago)
- Tunisia
- (Tunisia)
- Turkey
- (Turkey)
- Turkmenistan
- (Turkmenistan)
- Turks and Caicos Islands
- (Turks and Caicos Islands)
- Tuvalu
- (Tuvalu)
- Uganda
- (Uganda)
- Ukraine
- (Ukraine)
- United Arab Emirates
- (United Arab Emirates)
- United Kingdom (Great Britain)
- (United Kingdom (Great Britain))
- United States
- (United States)
- Uruguay
- (Uruguay)
- US Minor Outlying Islands
- (US Minor Outlying Islands)
- Uzbekistan
- (Uzbekistan)
- Vanuatu
- (Vanuatu)
- Vatican City State (Holy See)
- (Vatican City State (Holy See))
- Venezuela
- (Venezuela)
- Viet Nam
- (Viet Nam)
- Virgin Islands (British)
- (Virgin Islands (British))
- Virgin Islands (US)
- (Virgin Islands (US))
- Wales
- (Wales)
- Wallis and Futuna Islands
- (Wallis and Futuna Islands)
- Western Sahara
- (Western Sahara)
- Yemen
- (Yemen)
- Yugoslavia
- (Yugoslavia)
- Zaire
- (Zaire)
- Zambia
- (Zambia)
- Zimbabwe
- (Zimbabwe)
Population: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.
Age at death: age at which the individual deceased (when applicable):
- 35y = 35 years
- >43y = still alive at 43y
- 04y08m = 4 years and 8 months
- 00y00m01d12h = 1 day and 12 hours
- 18y? = around 18 years
- 30y-40y = between 30 and 40 years
- >54y = older than 54
- ? = unknown
VIP: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Data_av: are additional data available upon request: e.g. pedigree (yes/no/?)
Treatment: treatment of patient
Variants in genes: The individual has variants for this gene.
Panel size: Number of individuals this entry represents; e.g. 1 for an individual, 5 for a family with 5 affected members.

 Individual ID
|

 ID_report
|

 Reference
|
 Remarks
|

 Gender
|

 Consanguinity
|

 Country
|

 Population
|

 Age at death
|

 VIP
|

 Data_av
|

 Treatment
|

 Disease
|

 Phenotype details
|

 Variants
|

 Panel size
|

 Owner
|
00228665 |
son |
PubMed: van Kuilenburg 2018, Journal: van Kuilenburg 2018 |
- |
M |
- |
Netherlands |
- |
- |
- |
- |
- |
DPDD |
see paper; ..., born with apparent cortical blindness, subsequently exhibited severe
developmental delay; 2y-severe spasticity, hyperreflexia felt secondary to intrauterine stroke; multiple brain MRIs delay in myelination; 18y-spastic paraparesis, mild intellectual disability |
1 |
1 |
Johan den Dunnen |
00260657 |
patient |
PubMed: Rymen 2019, Journal: Rymen 2019 |
- |
F |
yes |
Switzerland |
- |
- |
- |
- |
- |
EDSCLL |
- |
1 |
1 |
Marco Ritelli |
00266303 |
Individual1 |
- |
- |
F |
- |
Italy |
- |
- |
- |
- |
- |
EDSCLL |
soft and hyperelastic skin, generalized joint hypermobility and related musculoskeletal complications, chronic constipation, showed progressive finger contractures and shortened metatarsals |
2 |
1 |
Lucia Micale |
00266304 |
individual2 |
- |
- |
F |
- |
Italy |
- |
26y |
- |
- |
- |
EDSCLL |
soft and hyperelastic skin, generalized joint hypermobility and related musculoskeletal complications, and chronic constipation |
2 |
1 |
Lucia Micale |
00275686 |
- |
- |
- |
F |
no |
- |
- |
>40y |
- |
- |
- |
EDSCLL |
- |
2 |
1 |
Corinne Metay |
00294068 |
- |
PubMed: Narang 2020, Journal: Narang 2020 |
analysis 2794 individuals (India) |
- |
- |
India |
- |
- |
- |
- |
- |
? |
- |
1 |
34 |
Mohammed Faruq |
00294069 |
- |
PubMed: Narang 2020, Journal: Narang 2020 |
analysis 2794 individuals (India) |
- |
- |
India |
- |
- |
- |
- |
- |
? |
- |
1 |
3 |
Mohammed Faruq |
00294071 |
- |
PubMed: Narang 2020, Journal: Narang 2020 |
analysis 2794 individuals (India) |
- |
- |
India |
- |
- |
- |
- |
- |
? |
- |
1 |
1 |
Mohammed Faruq |
00294072 |
- |
PubMed: Narang 2020, Journal: Narang 2020 |
analysis 2794 individuals (India) |
- |
- |
India |
- |
- |
- |
- |
- |
? |
- |
1 |
23 |
Mohammed Faruq |
00294073 |
- |
PubMed: Narang 2020, Journal: Narang 2020 |
analysis 2794 individuals (India) |
- |
- |
India |
- |
- |
- |
- |
- |
? |
- |
1 |
93 |
Mohammed Faruq |
00295989 |
- |
- |
- |
F |
- |
- |
- |
- |
- |
- |
- |
? |
Abnormality of the cerebral vasculature (HP:0100659); Intracranial hemorrhage (HP:0002170); Vasculitis (HP:0002633) |
1 |
1 |
Andreas Laner |
00296388 |
- |
- |
- |
M |
- |
- |
- |
- |
- |
- |
- |
? |
Abnormality of the atrial septum (HP:0011994); Abnormality of the aorta (HP:0001679); Secundum atrial septal defect (HP:0001684); Abnormality of connective tissue (HP:0003549); Dilatation of the ascending aorta (HP:0005111) |
1 |
1 |
Andreas Laner |
00300632 |
- |
- |
- |
M |
- |
Germany |
- |
- |
- |
- |
- |
? |
Muscular hypotonia (HP:0001252); Poor suck (HP:0002033); Facial hypotonia (HP:0000297); Oral motor hypotonia (HP:0030190); Limb-girdle muscle weakness (HP:0003325); Gowers sign (HP:0003391); Scapular winging (HP:0003691); Proximal muscle weakness (HP:0003701); Pelvic girdle muscle weakness (HP:0003749) |
2 |
1 |
Andreas Laner |
00305084 |
- |
PubMed: Narang 2020, Journal: Narang 2020 |
analysis 2794 individuals (India) |
- |
- |
India |
- |
- |
- |
- |
- |
? |
- |
1 |
1 |
Mohammed Faruq |
00316075 |
BO7 |
PubMed: Heidet 2017 |
- |
- |
- |
France |
- |
- |
- |
- |
- |
kidney disease |
preauricular pit, deafness |
1 |
1 |
Johan den Dunnen |
00316116 |
K169 |
PubMed: Heidet 2017 |
fetus |
- |
- |
France |
- |
- |
- |
- |
- |
CAKUT |
unilateral multicystic dysplasia; unilateral kidney agenesis |
1 |
1 |
Johan den Dunnen |
00317979 |
Fam1Pat1 |
PubMed: Hamada 2018 |
2-generation family, 1 affected, unaffected heterozygous carrier parents |
M |
no |
Japan |
- |
- |
- |
- |
- |
WEST |
see paper; ... |
1 |
1 |
Johan den Dunnen |
00319497 |
- |
PubMed: Zweers et al., 2005 |
The patient had normal TNX serum levels. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS |
- |
1 |
1 |
Raymond Dalgleish |
00319498 |
Family XI |
PubMed: Demirdas et al., 2016 |
The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319499 |
Family V |
PubMed: Demirdas et al., 2016 |
This patient was previously described in PubMed: Voermans et al., 2009.The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319500 |
Patient 2 |
PubMed: Micale et al., 2019 |
The patient carried a c.1150dupG variant and a pseudogene(TNXA)-derived 120bps deletion, likely the result of the formation of a chimeric TNXA/TNXB fusion gene. The technique used was the custom NGS Gene panel. |
- |
- |
Italy |
Italian |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319501 |
Patient 4 |
PubMed: Schalkwijk et al., 2001 |
This patient's parents were unavailable for study. The variant was incorrectly described as an insertion, rather than a duplication. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS |
Originally described as EDS Autosomal Recessive, |
1 |
1 |
Raymond Dalgleish |
00319502 |
Patient 1 |
PubMed: Micale et al., 2019 |
The patient carried a c.8278C>T variant and a deletion including exons 5 and 6, generating a frameshift with the insertion of a premature stop codon. The exact start and end points of the deletion were uncertain. The technique used was the custom NGS Gene panel. |
- |
- |
Italy |
Italian |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319503 |
Family IX |
PubMed: Demirdas et al., 2016 |
The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319504 |
- |
- |
The testing laboratory (University of Nebraska Medical Center) describes this variant as being of Uncertain Clinical Significance.The status of patient's disease classification has been changed from EDS III to undiagnosed on the basis of further clinical tests - 3 May 2017. The technique used was the custom NGS Gene panel. |
- |
- |
- |
white |
- |
- |
- |
- |
EDS, EDSHMB |
- |
1 |
1 |
James Bertz |
00319505 |
- |
PubMed: Sakiyama et al., 2015 |
The patient had recurrent gastrointenstinal perforation.The technique used was the custom NGS Gene panel. |
- |
- |
Japan |
Japanese |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319506 |
Family III |
PubMed: Demirdas et al., 2016 |
The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319507 |
Family VIII |
PubMed: Demirdas et al., 2016 |
The patient carried a TNXB/TNXA fusion gene with a 30kb deletion encompassing CYP21A2 on the allele from Parent #2. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
3 |
1 |
Raymond Dalgleish |
00319508 |
- |
PubMed: Tokhmafshan et al., 2020 |
- |
- |
- |
- |
European (non-Finnish) |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319509 |
Patient 1 |
PubMed: Schalkwijk et al., 2001, PubMed: Voermans et al., 2007, PubMed: Voermans et al., 2007 |
This patient's mother was deceased, but the patient's sister was heterozygous for the variant, with the maternal allele carrying the deletion |
- |
- |
- |
- |
- |
- |
- |
- |
EDS |
Originally described as EDS Autosomal Recessive, |
1 |
1 |
Raymond Dalgleish |
00319510 |
Patient 5 |
PubMed: Schalkwijk et al., 2001 |
This patient's parents were unavailable for study. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS |
Originally described as EDS Autosomal Recessive, |
1 |
1 |
Raymond Dalgleish |
00319511 |
Family VII |
PubMed: Demirdas et al., 2016 |
This patient was previously described as Patient 2 in {PMID 21959861:Hendriks et al., 2012}. The patient carried a TNXB/TNXA fusion gene from Parent#2 with a 30kb deletion encompassing CYP21A2. The fusion gene carried the described variants. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
3 |
1 |
Raymond Dalgleish |
00319512 |
- |
PubMed: Zweers et al., 2005 |
The patient had normal TNX serum levels.The variant is incorrectly described by the authors as 3583AG. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSHMB |
- |
1 |
1 |
Raymond Dalgleish |
00319513 |
- |
PubMed: Tokhmafshan et al., 2020 |
- |
- |
- |
- |
European (non-Finnish) |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319514 |
- |
PubMed: Mackenroth et al., 2016 |
The patient also harbours the COL1A1 variant c.4006-1G>A.The technique used was whole exome sequencing. |
- |
- |
Germany |
German |
- |
- |
- |
- |
EDS |
osteogenesis imperfecta/Ehlers-Danlos syndrome overlap, |
2 |
1 |
Raymond Dalgleish |
00319515 |
Family 2 |
PubMed: Gbadegesin et al., 2013 |
- |
- |
- |
- |
white |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319516 |
- |
PubMed: Lee et al., 2014 |
The technique used was whole genome sequencing. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSHMB |
- |
1 |
1 |
Raymond Dalgleish |
00319517 |
- |
PubMed: Kaufman and Butler, 2016 |
The technique used was the custom NGS Gene panel. |
- |
- |
- |
Jewish-Ashkenazi |
- |
- |
- |
- |
EDS, EDSCLL |
- |
1 |
1 |
Raymond Dalgleish |
00319518 |
- |
PubMed: Tokhmafshan et al., 2020 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319519 |
- |
PubMed: Tokhmafshan et al., 2020 |
- |
- |
- |
- |
European (non-Finnish) |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319520 |
- |
- |
The patient's older affected sister also harbours the duplication sequence variant. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSHMB |
- |
2 |
1 |
Sandra Gajewski |
00319521 |
- |
PubMed: Wang et al., 2018 |
The variants cause susceptibility towards the phenotype, but are not confirmed to be pathogenic in isolation. The technique used was whole exome sequencing. |
- |
- |
China |
Han Chinese |
- |
- |
- |
- |
? |
Artery dissections, |
2 |
1 |
Raymond Dalgleish |
00319522 |
- |
PubMed: Gbadegesin et al., 2013 |
The variant was described in the published account as ENST00000375244:c.9770C>TThe technique used was whole exome sequencing. |
- |
- |
- |
white |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319523 |
- |
PubMed: Tokhmafshan et al., 2020 |
- |
- |
- |
- |
South Asian |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319524 |
- |
- |
Performed by Prevention Genetics.The proband's sister and daughter also harbour the same variant but are not definitively diagnosed as having EDS III. |
- |
- |
England;Netherlands |
English, Dutch |
- |
- |
- |
- |
EDS, EDSHMB |
- |
1 |
1 |
Michelle Dolan |
00319525 |
- |
- |
- |
- |
- |
Germany |
German |
- |
- |
- |
- |
EDS, EDSHMB |
- |
1 |
1 |
Karina Sturm |
00319526 |
- |
PubMed: Tokhmafshan et al., 2020 |
- |
- |
- |
- |
European (non-Finnish) |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00319527 |
Family II |
PubMed: Demirdas et al., 2016 |
This patient was previously described in PubMed: Schalkwijk et al., 2001 as Patient 2. There are two other siblings carrying the same variant and phenotype. The variants are TNXA-derived, probably due to the formation of a chimeric gene. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319528 |
Family IV |
PubMed: Demirdas et al., 2016 |
This family was previously described in PubMed: Voermans et al., 2009. The patient carried a TNXB/TNXA fusion gene on the allele for Parent #1, causing a 30kb deletion encompassing CYP21A2. The fusion gene carried the described variants. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
2 |
1 |
Raymond Dalgleish |
00319529 |
- |
PubMed: Lao et al., 2019 |
26 patients with congenital adrenal hyperplasia showed evidence of the CAH-X CH-1 genotype, a chimeric TNXA/TNXB gene featuring the described variant. Up to 24 patients had a complete or partial clinical evaluation for EDS. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia, EDS |
- |
1 |
1 |
Raymond Dalgleish |
00319530 |
- |
PubMed: Zweers et al., 2005 |
The patient had normal TNX serum levels.The variant is incorrectly described by the authors as 12097CA.This is a common sequence variant which is unlikely to be disease-causing. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSHMB |
- |
1 |
1 |
Raymond Dalgleish |
00319531 |
Family 1: II-2 |
PubMed: Morissette et al., 2015 |
The patient and his father carried a pseudogene-derived variant from the formation of a chimeric gene between TNXA and TNXB. They showed some characteristics of hypermobile EDS.The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia |
- |
1 |
1 |
Raymond Dalgleish |
00319532 |
Family 2: II-1 |
PubMed: Morissette et al., 2015 |
The patient and her mother carried a pseudogene-derived variant from the formation of a chimeric gene between TNXA and TNXB. They had several characteristics of hypermobile EDS. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia |
- |
1 |
1 |
Raymond Dalgleish |
00319533 |
Family 3: II-1 |
PubMed: Morissette et al., 2015 |
The patient and her mother carried a pseudogene-derived variant from the formation of a chimeric gene between TNXA and TNXB. They showed some characteristics of hypermobile EDS.The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia |
- |
1 |
1 |
Raymond Dalgleish |
00319534 |
Family 4: II-2 |
PubMed: Morissette et al., 2015 |
The patient and his father carried a pseudogene-derived variant from the formation of a chimeric gene between TNXA and TNXB. They showed significant characteristics of hypermobile EDS.The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia |
- |
1 |
1 |
Raymond Dalgleish |
00319535 |
Family 5: II-3 |
PubMed: Morissette et al., 2015 |
The patient and her father carried a pseudogene-derived variant from the formation of a chimeric gene between TNXA and TNXB. Both patients showed characteristics of hypermobile EDS, and the father showed no CAH phenotype. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia |
- |
1 |
1 |
Raymond Dalgleish |
00319536 |
Family 6: II-1 |
PubMed: Morissette et al., 2015 |
The patient, her mother, and brother carried a pseudogene-derived variant from the formation of a chimeric gene between TNXA and TNXB. The mother was a carrier for CAH, but did not display the phenotype. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia |
- |
1 |
1 |
Raymond Dalgleish |
00319537 |
Family 7:II-3 |
PubMed: Morissette et al., 2015 |
The patient, her mother, and sister carried a pseudogene-derived variant from the formation of a chimeric gene between TNXA and TNXB. The mother and sister were carriers for CAH, but did not display the phenotype.The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia |
- |
1 |
1 |
Raymond Dalgleish |
00319538 |
P1 |
PubMed: Chen et al., 2016 |
The patient is homozygous for a three variant cluster, c. 12218G>A, c.12514G>A, and c.12524G>A, which authors present as a novel chimeric form causing CAH and TNXB haploinsufficiency. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia, EDS |
- |
4 |
1 |
Raymond Dalgleish |
00319539 |
P2 |
PubMed: Chen et al., 2016 |
The patient inherited a three variant cluster, c. 12218G>A, c.12514G>A, and c.12524G>A, which authors present as a novel chimeric form causing CAH and TNXB haploinsufficiency. The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia, EDS |
- |
4 |
1 |
Raymond Dalgleish |
00319540 |
P3 |
PubMed: Chen et al., 2016 |
The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia, EDS |
- |
1 |
1 |
Raymond Dalgleish |
00319541 |
Family X |
PubMed: Demirdas et al., 2016 |
This patient was previously described in {PMID21959861:Hendriks et al., 2012}. The patient carries a TNXB/TNXA fusion gene with a 30kb deletion encompassing CYP21A2 on the allele from Parent #1.The technique used was the custom NGS Gene panel. |
- |
- |
- |
- |
- |
- |
- |
- |
EDS, EDSCLL |
- |
1 |
1 |
Raymond Dalgleish |
00319542 |
- |
PubMed: Lao et al., 2019 |
18 patients with congenital adrenal hyperplasia carried the CAH-X CH-2 genotype, a chimeric TNXA/TNXB gene carrying the described variants. Up to 16 patients had a complete or partial clinical evaluation for EDS. |
- |
- |
- |
- |
- |
- |
- |
- |
adrenal hyperplasia, EDS |
- |
1 |
1 |
Raymond Dalgleish |
00319543 |
- |
PubMed: Pénisson-Besnier et al., 2013 |
This patient's maternal allele carries a complex rearrangement, which was first described by {PMID9288108:Burch et al., 1997}. |
- |
- |
- |
- |
- |
- |
- |
- |
EDSCLL |
TNXB deficiency, |
1 |
1 |
Raymond Dalgleish |
00319544 |
- |
PubMed: Penisson-Besnier |
The patient carried a TNXA/TNXB fusion gene with a 30kb deletion on one allele, and the c.12214C>T variant on the other allele. His father and brother were asymptomatic and heterozygous for only the substitution variant. Authors predict that the variant is only pathogenic when compound heterozygous with another null allele. |
- |
- |
- |
- |
- |
- |
- |
- |
EDSCLL |
TNXB deficiency, |
1 |
1 |
Raymond Dalgleish |
00319545 |
- |
PubMed: Tokhmafshan et al., 2020 |
- |
- |
- |
- |
European (non-Finnish) |
- |
- |
- |
- |
VUR8 |
- |
1 |
1 |
Raymond Dalgleish |
00376129 |
private email |
contact me for details |
- |
F |
yes |
(United States) |
Italy |
- |
- |
- |
- |
EDS |
presents with a severe form of hypermobile Ehlers Danlos syndrome |
1 |
1 |
Johan den Dunnen |
00397593 |
patient |
- |
- |
F |
yes |
United States |
Italy |
- |
- |
- |
- |
EDS, neuropathy, peripheral |
Easy bruising
Velvety skin
Elastic like skin
Chronic musclskeletal pain
Hypermobile joints |
1 |
1 |
Noelle Pastor |
00413441 |
patient |
PubMed: Burch 1997 |
- |
M |
- |
United States |
- |
- |
- |
- |
- |
? |
see paper; ..., congenital adrenal hyperplasia, 21-hydroxylase deficiency, hyperextensible skin, hyperextensible joints, easy bruising, poor wound healing |
1 |
1 |
Johan den Dunnen |
00413442 |
Pat2 |
PubMed: Schalkwijk 2001 |
3-generation family, 3 affected (2F, M), unaffected heterozygous carrier parents |
F |
- |
Netherlands |
- |
- |
- |
- |
- |
EDS |
- |
1 |
1 |
Johan den Dunnen |
00413443 |
Pat3 |
PubMed: Schalkwijk 2001 |
2-generation family, 1 affected, unaffected heterozygous carrier parents |
F |
- |
Netherlands |
- |
- |
- |
- |
- |
EDS |
congenital adrenal hyperplasia, Ehlers-Danlos syndrome |
1 |
1 |
Johan den Dunnen |
00413448 |
- |
PubMed: Colman 2021, Journal: Colman 2021 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EDS |
- |
1 |
1 |
Johan den Dunnen |
00413449 |
- |
PubMed: Colman 2021, Journal: Colman 2021 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EDS |
- |
1 |
1 |
Johan den Dunnen |
00414433 |
WHP100 |
PubMed: Sun 2018 |
- |
F |
- |
China |
- |
- |
- |
- |
- |
? |
Finnish type Amyloidosis;Alport Syndrome;Vesicoureteral Reflux 8 |
1 |
1 |
LOVD |
00434896 |
4 |
PubMed: Fransen et al., 2021 |
34 candidate genes targeted from 787 independent keratoconus patients and 856 ethnically matched controls, including results from unpublished studies and literature search. 7 patients with EDS gene variants. |
? |
no |
Belgium |
- |
- |
- |
- |
- |
EDS, KCTN1 |
Diagnosis was based on slit-lamp biomicroscopy and tomographic evaluation of the cornea., Hypermobility, fragile skin, easy bruising. |
1 |
1 |
Nassim Louail |
00435339 |
Patient 1 |
- |
- |
F |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
1 |
1 |
Tomoki Kosho |
00435340 |
Patient 2 |
- |
- |
M |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
1 |
1 |
Tomoki Kosho |
00435341 |
Patient 3 |
- |
- |
M |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
1 |
1 |
Tomoki Kosho |
00435342 |
Patient 4 |
- |
- |
F |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
2 |
1 |
Tomoki Kosho |
00435344 |
Patient 5 |
- |
- |
F |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
2 |
1 |
Tomoki Kosho |
00435346 |
Patient 6 |
- |
- |
F |
- |
China |
- |
- |
- |
- |
- |
EDSCLL |
- |
1 |
1 |
Tomoki Kosho |
00435348 |
Patient 7 |
- |
- |
M |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
2 |
1 |
Tomoki Kosho |
00435349 |
Patient 8 |
- |
- |
F |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
2 |
1 |
Tomoki Kosho |
00435351 |
Patient 9 |
- |
- |
F |
- |
Japan |
- |
- |
- |
- |
- |
EDSCLL |
- |
2 |
1 |
Tomoki Kosho |
00448368 |
private email |
contact me for details |
- |
M |
no |
(Slovenia) |
white |
>16y |
- |
- |
- |
EDS |
- |
1 |
1 |
Johan den Dunnen |